Pharma-Bio Serv, Inc. (PBSV) Comparison with companies in other sectors?

Pharma-Bio Serv, Inc. has a share price of 22.93M. You can analyze Pharma-Bio Serv, Inc. (PBSV) competitors across different market sectors through stock heatmaps.

What are PBSV's NET and operating margins?

Pharma-Bio Serv, Inc. (PBSV) operating margin is around -0.08, and net profit margin is approximately -0.02 as of the latest reports.

In what way does PBSV's earnings per share (EPS) trend reflect its financial momentum?

Pharma-Bio Serv, Inc. (PBSV) EPS is -0.01 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Pharma-Bio Serv, Inc. is -60.00, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Pharma-Bio Serv, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Pharma-Bio Serv, Inc. like P/E which is -72.73, P/B which is 1.14, and PEG which is -13.82. Compare them with sector averages to evaluate if the stock is priced fairly.

Pharma-Bio Serv, Inc.

PBSV•PNK

Healthcare

Medical - Healthcare Information Services

$0.60

$0.00(0.00%)

Pharma-Bio Serv, Inc. (PBSV) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-0.01

P/E Ratio

-60.00

ROE

-0.00%

Net Margin

-0.02%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$13.76M

Shares OutstandingTotal number of shares issued

$22.93M

Book Value/ShareNet worth per share

$0.53

Revenue/ShareAnnual revenue per share

$0.42

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.01

Net MarginNet income as percentage of revenue

-1.96%

Operating MarginOperating income as percentage of revenue

-7.54%

ROEReturn on shareholders' equity

-0.01%

ROAReturn on total assets

-1.36%

ROCEReturn on capital employed

-5.99%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.06

Cash/ShareCash and equivalents per share

$0.45

FCF YieldFree cash flow as percentage of market cap

-10.80%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.07

Dividend YieldAnnual dividend as percentage of stock price

12.50%

Financial Ratios Analysis data is not available for PBSVFinancial Ratios Analysis details for PBSV are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for PBSVSector Benchmarking details for PBSV are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Pharma-Bio Serv, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Pharma-Bio Serv, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Pharma-Bio Serv, Inc.'s unique business strengths and challenges.

Key Financial Metrics for Pharma-Bio Serv, Inc.

For Pharma-Bio Serv, Inc., essential financial indicators include EPS -0.01, PE -60.00, and ROE -0.00. These key ratios reveal insights into Pharma-Bio Serv, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Pharma-Bio Serv, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Pharma-Bio Serv, Inc.

Metrics like Net Margin -1.96% and ROA -1.36% shed light on how well Pharma-Bio Serv, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Pharma-Bio Serv, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Pharma-Bio Serv, Inc.

Using ratios such as P/B Ratio 1.14 and PEG Ratio -13.82, investors can assess whether Pharma-Bio Serv, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Pharma-Bio Serv, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Pharma-Bio Serv, Inc.

Financial health indicators, such as Debt/Equity Ratio 0.009 and Cash Flow $-0.06, provide a snapshot of Pharma-Bio Serv, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Pharma-Bio Serv, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Pharma-Bio Serv, Inc.

Investing in Pharma-Bio Serv, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Pharma-Bio Serv, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;